8-K/A XBRL

8-K/A Filing

Company: Hepion Pharmaceuticals, Inc.
Filed: April 4, 2025
Period of Report: March 4, 2025
Accession Number: 0001641172-25-002775

View Document ↗ View on SEC.gov ↗